DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Erickson HK, Park PU, Widdison WC, Kovtun YV, Garrett LM, Hoffman K. et al.
Antibody-maytansinoid conjugates are activated in targeted cancer cells by lysosomal degradation and linker-dependent intracellular processing.
Cancer Res 2006;
66: 4426-33
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.